ORAL CAVITY CARCINOMA
Clinical trials for ORAL CAVITY CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ORAL CAVITY CARCINOMA trials appear
Sign up with your email to follow new studies for ORAL CAVITY CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy duo takes on rare tumors in major trial
Disease control OngoingThis study tests whether combining two immunotherapy drugs, nivolumab and ipilimumab, can shrink tumors in people with rare cancers. About 800 participants with over 50 different rare tumor types received these drugs to boost their immune system's ability to fight cancer. The goa…
Matched conditions: ORAL CAVITY CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 15, 2026 19:03 UTC
-
HPV vaccine under the microscope: Decades-Long study tracks Real-World protection
Knowledge-focused OngoingThis study follows thousands of women in Costa Rica who received the HPV vaccine (types 16 and 18) and compares them to unvaccinated women. Researchers want to see how long the vaccine protects against cervical cancer and related diseases, and whether it might lead to more infect…
Matched conditions: ORAL CAVITY CARCINOMA
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:06 UTC